# Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

> **NCT04817904** · PHASE2 · UNKNOWN · sponsor: **Cairo University** · enrollment: 65 (estimated)

## Conditions studied

- Cisplatin Adverse Reaction

## Interventions

- **DRUG:** Rosuvastatin 10mg

## Key facts

- **NCT ID:** NCT04817904
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-17
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04817904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04817904, "Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04817904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*